1. Home
  2. DNLI vs CVSA Comparison

DNLI vs CVSA Comparison

Compare DNLI & CVSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Denali Therapeutics Inc.

DNLI

Denali Therapeutics Inc.

HOLD

Current Price

$19.72

Market Cap

3.2B

Sector

Health Care

ML Signal

HOLD

CVSA

Covista Inc. Common Shares

N/A

Current Price

$101.95

Market Cap

3.4B

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
DNLI
CVSA
Founded
2013
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.4B
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
DNLI
CVSA
Price
$19.72
$101.95
Analyst Decision
Strong Buy
Buy
Analyst Count
11
1
Target Price
$30.00
$170.00
AVG Volume (30 Days)
1.4M
404.2K
Earning Date
05-28-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$10.11
Revenue Next Year
$291.12
$6.65
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.57
$96.08
52 Week High
$23.77
$103.57

Technical Indicators

Market Signals
Indicator
DNLI
CVSA
Relative Strength Index (RSI) 45.90 N/A
Support Level $13.28 N/A
Resistance Level $20.12 N/A
Average True Range (ATR) 1.11 0.00
MACD -0.15 0.00
Stochastic Oscillator 25.00 0.00

Price Performance

Historical Comparison
DNLI
CVSA

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

Share on Social Networks: